MediPal Holdings Corporation

TSE:7459 Rapporto sulle azioni

Cap. di mercato: JP¥525.9b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

MediPal Holdings Performance dei guadagni passati

Il passato criteri di controllo 2/6

MediPal Holdings has been growing earnings at an average annual rate of 3.3%, while the Healthcare industry saw earnings growing at 6.6% annually. Revenues have been growing at an average rate of 2.1% per year. MediPal Holdings's return on equity is 6.7%, and it has net margins of 1.1%.

Informazioni chiave

3.3%

Tasso di crescita degli utili

4.1%

Tasso di crescita dell'EPS

Healthcare Crescita del settore7.9%
Tasso di crescita dei ricavi2.1%
Rendimento del capitale proprio6.7%
Margine netto1.1%
Ultimo aggiornamento sui guadagni30 Jun 2024

Aggiornamenti sulle prestazioni recenti

Concerns Surrounding MediPal Holdings' (TSE:7459) Performance

May 22
Concerns Surrounding MediPal Holdings' (TSE:7459) Performance

Recent updates

MediPal Holdings (TSE:7459) Has Announced A Dividend Of ¥30.00

Aug 06
MediPal Holdings (TSE:7459) Has Announced A Dividend Of ¥30.00

MediPal Holdings Corporation (TSE:7459) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Aug 05
MediPal Holdings Corporation (TSE:7459) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Returns On Capital At MediPal Holdings (TSE:7459) Have Hit The Brakes

Jun 25
Returns On Capital At MediPal Holdings (TSE:7459) Have Hit The Brakes

Concerns Surrounding MediPal Holdings' (TSE:7459) Performance

May 22
Concerns Surrounding MediPal Holdings' (TSE:7459) Performance

Some Confidence Is Lacking In MediPal Holdings Corporation's (TSE:7459) P/E

May 08
Some Confidence Is Lacking In MediPal Holdings Corporation's (TSE:7459) P/E

Ripartizione dei ricavi e delle spese

Come MediPal Holdings guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.


Storia dei guadagni e delle entrate

TSE:7459 Ricavi, spese e utili (JPY Millions )
DataRicaviGuadagniSpese G+ASpese di R&S
30 Jun 243,581,31239,294188,0120
31 Mar 243,558,73241,474185,6770
31 Dec 233,507,50537,244178,3600
30 Sep 233,453,60138,636177,3410
30 Jun 233,408,41741,724167,2920
31 Mar 233,360,00838,806163,1430
31 Dec 223,351,06930,439165,2300
30 Sep 223,333,07328,222161,0210
30 Jun 223,304,37228,248160,2790
31 Mar 223,290,92129,423159,4870
31 Dec 213,279,58336,411158,3000
30 Sep 213,265,95130,523158,6340
30 Jun 213,241,83826,468160,9950
31 Mar 213,211,12523,926162,9080
31 Dec 203,208,23726,682166,8750
30 Sep 203,186,65133,329168,4720
30 Jun 203,236,31537,002169,7430
31 Mar 203,253,07937,968171,1350
31 Dec 193,242,84034,722170,2260
30 Sep 193,253,49535,443170,7530
30 Jun 193,189,61334,116170,7880
31 Mar 193,181,92834,359171,1520
31 Dec 183,178,57834,315171,1010
30 Sep 183,169,34434,122171,4980
30 Jun 183,169,21637,166170,4460
31 Mar 183,146,31434,780170,5820
31 Dec 173,124,72433,199170,5180
30 Sep 173,093,74331,086169,5170
30 Jun 173,072,59726,239169,0380
31 Mar 173,063,90029,011167,8530
31 Dec 163,065,83332,149168,9600
30 Sep 163,072,86832,201167,8790
30 Jun 163,057,50133,965166,2920
31 Mar 163,028,18730,771164,5740
31 Dec 152,995,21028,449159,8180
30 Sep 152,953,70726,052158,5980
30 Jun 152,923,06123,938157,9620
31 Mar 152,872,90523,687158,3480
31 Dec 142,902,88922,221160,8750
30 Sep 142,909,85821,592161,9710
30 Jun 142,920,80822,231162,8760
31 Mar 142,947,79825,485163,1750
31 Dec 132,883,61523,157172,9960
30 Sep 132,860,46719,380173,4650

Guadagni di qualità: 7459 has high quality earnings.

Margine di profitto in crescita: 7459's current net profit margins (1.1%) are lower than last year (1.2%).


Flusso di cassa libero e analisi degli utili


Analisi della crescita degli utili nel passato

Andamento degli utili: 7459's earnings have grown by 3.3% per year over the past 5 years.

Accelerare la crescita: 7459's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Guadagni vs Settore: 7459 had negative earnings growth (-5.8%) over the past year, making it difficult to compare to the Healthcare industry average (8.1%).


Rendimento del capitale proprio

ROE elevato: 7459's Return on Equity (6.7%) is considered low.


Rendimento delle attività


Rendimento del capitale investito


Scoprire le aziende con forti performance passate